Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

Lai, 2020, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges, Int. J. Antimicrob. Agents, 55, 10.1016/j.ijantimicag.2020.105924 WHO Director-General'’s opening remarks at the media briefing on COVID-19 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 CASES FROM THE Chinese center for disease control and prevention, JAMA, 323, 1239, 10.1001/jama.2020.2648 WHO Zhang, 2020, Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality, Int. J. Antimicrob. Agents, 55, 10.1016/j.ijantimicag.2020.105954 Fu, 2020, Why tocilizumab could be an effective treatment for severe COVID-19?, J. Transl. Med., 18, 164, 10.1186/s12967-020-02339-3 Stone, 2020, Tocilizumab trial investigators. Efficacy of tocilizumab in patients hospitalized with Covid-19, N. Engl. J. Med., 383, 2333, 10.1056/NEJMoa2028836 Mikulska, 2020, Tocilizumab and steroid treatment in patients with COVID-19 pneumonia, PLoS One, 15, 10.1371/journal.pone.0237831 Somers, 2020, Tocilizumab for treatment of mechanically ventilated patients with COVID-19, Clin. Infect. Dis., 10.1093/cid/ciaa954 Ip, 2020, Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-an observational study, PLoS One, 15, 10.1371/journal.pone.0237693 Rodríguez-Baño, 2020, Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19), Clin. Microbiol. Infect. Colaneri, 2020, Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE), Microorganisms, 8, 10.3390/microorganisms8050695 Biran, 2020, Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study, Lancet Rheumatol., 2, e603, 10.1016/S2665-9913(20)30277-0 Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41 Coscia Requena, 2018, Analysis of causality from observational studies and its application in clinical research in intensive care medicine, Med. Int., 42, 292 Rodríguez-Molinero, 2020, Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study, Med Clin (Engl Ed)., 27 Rodríguez-Molinero, 2020, COVID-19 research group of CSAPG. Observational study of azithromycin in hospitalized patients with COVID-19, PLoS One, 15, 10.1371/journal.pone.0238681 Anonymous